Cardinal Health is overvalued, with a dividend yield lower than its historical average and a high P/E ratio. Growth projections for the Company are moderate, with a projected growth rate of 7.8% ...

Cardinal Health's pharmaceutical distribution contracts with OptumRx, a subsidiary of UnitedHealth Group, will not be renewed, the medical distributor said April 22. The contracts, which mainly ...

(Reuters) - Cardinal Health said on Monday its contracts with UnitedHealth Group's OptumRx, one of its largest customers, will not be renewed after they expire at the end of June, sending the drug ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cardinal Health Inc.’s shares CAH, -0.84% fell 2% premarket Thursday after the company reported mixed results for its fiscal third quarter but raised its full-year profit outlook. The drug ...

Cardinal Health said its contracts with the pharmacy benefits provider of UnitedHealth Group, OptumRX, won't be renewed, and shares fell in intraday trading Monday. The health insurer noted that ...

Analyst George Hill of Deutsche Bank maintained a Hold rating on Cardinal Health (CAH – Research Report), with a price target of $110.00. George Hill has given his Hold rating due to a ...

Cardinal Health (NYSE:CAH) shares fell 5% on Monday after the company said its pharmaceutical distribution contracts with UnitedHealth Group’s (NYSE:UNH) OptumRx unit will not be renewed ...

Jack is a career business journalist an an award-winning podcast host. Back in August 2022, when Cardinal Health, Inc.’s finance chief, Jason Hollar, succeeded CEO Mike Kaufmann as the ...

Cardinal Health said. Cardinal said it expects to partially offset the impact of losing the Optum contracts through customer additions and growth in its more profitable specialty pharmacy business.